Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.04
(
1.15%
)
US TECH 100
23,634.80
(
1.51%
)
Dow Jones
46,208.53
(
1.38%
)
Brent Oil
96.82
(
-10.46%
)
Bitcoin
70,595.29
(
4.07%
)
News Focus
News Focus
Post# of 257272
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 115378

Tuesday, 06/14/2011 2:55:36 PM

Tuesday, June 14, 2011 2:55:36 PM

Post# of 257272

I disagree with the implication that Denosumab cannot extend survival and with the assertion that Denosumab is not an “anti-cancer” drug.

The results from the Alpharadin (radium-223 chloride) trial #msg-63944830 show that a bone targeted therapy (not an “anti-cancer” drug) can improve OS in CRPC patients with bone metastases.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today